ClinicalTrials.gg
Drug

Imiquimod clinical trials

Also written Aldara and Zyclara.

studies test it
123
open now
8
in phase 3
36
first study started
1999

How each study uses Imiquimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Imiquimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Feb 1997 · ALDARA · NDA 020723 (FDA, Drugs@FDA)
European Union
18 Sept 1998 · Aldara · EMEA/H/C/000179 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Imiquimod
65
Imiquimod 5% cream
14
imiquimod cream
9
R 837
5
IMQ
4

Brand

Aldara
39
Zyclara
3

Development codes

TMX-101
1

Studies by the year they started

120 studies that test it; most in 2008 (16)

Studies that test Imiquimod, by start year
YearStudies
19991
20002
20012
20024
20032
20044
200510
20065
20074
200816
20097
20104
20114
20126
20135
20146
20155
20167
20172
20183
20195
20202
20213
20222
20231
20243
20253
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
25
Phase 2
30
Phase 3
36
Phase 4
23
No phase
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 93

Graceway Pharmaceuticals, LLC (10) · MEDA Pharma GmbH & Co. KG (8) · The University of Hong Kong (4) · Maastricht University Medical Center (4) · University Hospital Tuebingen (3) · Medical University of Graz (3) · Medical University of Vienna (3) · University of Michigan (2)

Often tested with

Tested in the same studies.

Fluorouracil (5) · Pembrolizumab (2) · Cyclophosphamide (2) · Candida albicans Antigen Injection (1) · Histamine phosphate (1) · Histamine (1) · Human Papillomavirus Recombinant Vaccine nonavalent (1) · Human Papillomavirus Tumor Antigen Vaccine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test Imiquimod.

Studies

Open first, then newest update. How each study uses Imiquimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 123

See all 123 studies that test Imiquimod →

Given beside what is tested · 21 — Imiquimod is usual care or a partner of the new treatment

Showing 20 of 21.

As the comparator · 10 — what is tested is compared with Imiquimod

What changed recently

From the registry's own updates since Oct 20, 2026.

Newly registered1

Codes

What other systems call Imiquimod · ClinicalTrials.gg INT006684

  • MeSH (NLM) D000077271ImiquimodConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) P1QW714R7MIMIQUIMODConfirmed FDA, NLM, Wikidata
  • RxNorm 59943Confirmed FDA, Wikidata
  • Wikidata Q423417imiquimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1431ImiquimodOne source FDA
  • DrugBank DB00724One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.